BioCryst Pharmaceuticals Inc (BCRX) — Cash Flow Quality Index
BioCryst Pharmaceuticals Inc (BCRX) has a Cash Flow Quality Index of 0.76x as of December 2025. Operating cash flow of $276.04 Million is below net income of $362.26 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of BioCryst Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioCryst Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for BioCryst Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is BioCryst Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioCryst Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for BioCryst Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is BioCryst Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.25x | $329.88 Million | $263.86 Million | — |